Immuron (IMRN) Change in Receivables (2016 - 2023)
Immuron (IMRN) posted quarterly Change in Receivables of $2.2 million for Q4 2023, up 281.59% year-over-year from $583772.0 in Q4 2022, and up 281.59% quarter-over-quarter from $583772.0 in Q4 2022.
Immuron (IMRN) Change in Receivables (2016 - 2023) Analysis & Trends
Immuron's Change in Receivables history runs 6 years deep, the most recent figure standing at $2.2 million for Q4 2023.
- In Q4 2023, Change in Receivables rose 281.59% year-over-year to $2.2 million; the TTM figure through Dec 2023 stood at $2.6 million (up 231.59% YoY), while the FY2025 annual figure was $361172.0, down 42.54% from the prior year.
- Change in Receivables for Q4 2023 stood at $2.2 million, up from $583772.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.2 million in Q4 2023, with the low at -$241381.0 in Q2 2022.
- The 4-year median for Change in Receivables is $420279.3 (2020), against an average of $601605.0.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables slumped 1460.68% in 2022, then soared 281.59% in 2023.
- Immuron's Change in Receivables stood at $420279.3 in 2020, then slumped by 95.78% to $17739.8 in 2021, then surged by 3190.75% to $583772.0 in 2022, then jumped by 281.59% to $2.2 million in 2023.
- Business Quant data shows IMRN's Change in Receivables at $2.2 million in Q4 2023, $583772.0 in Q4 2022, and -$241381.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2022 | 583,772.00 |
| Dec 31, 2022 | 583,772.00 |
| Jun 30, 2022 | -241,380.99 |
| Jun 30, 2022 | -241,380.99 |
| Jun 30, 2021 | 17,739.76 |
| Jun 30, 2021 | 17,739.76 |
| Jun 30, 2020 | 420,279.30 |
| Jun 30, 2020 | 420,279.30 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2017 | 923,408.71 |
| Dec 31, 2016 | 501,319.99 |
| Dec 31, 2016 | 501,319.99 |